Interferon α sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: Case report and review of literature

Journal of Clinical Pathology

Volumn 59, Issue 8, 2006, Pages 879-881

  Colovic, M ^a   Jurisic, Vladimir ^b   Jankovic, G ^a   Jovanovic, D ^c   Nikolic, L J ^a   Dimitrijevic, J ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA INTERFERON; CYTARABINE; DIURETIC AGENT; METHYLPREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON;

ADULT; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COOMBS TEST; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG TOLERANCE; FACE EDEMA; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MICTURITION DISORDER; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; REVIEW;

EID: 33747043387     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.027797     Document Type: Review

References (22)

1. Utsch B, Fleischhack G, Hasan C, et al. Nephrotic syndrome as paraneoplastic syndrome of Hodgkin disease. Eur J Pediatr 1999;158:768.
2. Queseda JT, Talpaz M, Rios A, et al. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986;4:234-43.
3. Budak-Alpdogen T, Lawrence RA, Bayik M, et al. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia. Clin Nephrol 1997;48:59-60.
4. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002;107:133-44.
5. Selby P, Kohn J, Raymond J, et al. Nephrotic syndrome during treatment with interferon. BMJ 1985;290:1180.
6. Altraif IH, Abdulla AS, al Sebayel MI, et al. Hepatitis C associated glomerulonephritis. Am J Nephrol 1995;15:407-10.
7. Coroneos E, Petrusevska G, Varghese F, et al. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis 1996;28:2401-7.
8. Bremer CAT, Lastrapes A, Alper AB, et al. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myleogenous leukemia. A case report and review of the literature. Am J Clin Oncol 2003;26:262-4.
9. Shah M, Jenis EH, Mookerjee BK, et al. Interferon-α-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer 1998;83:1938-46.
10. Horowitz R, Glocklich D, Sablay L, et al. Interferon-induced reversible acute renal failure: a case report and literature review. Med Oncol 1995;12:55-7.
11. Gagoo ES, Luno E, Quinones L, et al. Chronic mylogenous leukemia and glomerulonephritis: report of a new case. Am J Med 1986;81:1121-2.
12. Sudholt BA, Heirnonimus JD. Chronic myelogenous leukemia with nephrotic syndrome. Arch Intern Med 1983;143:168-9.
13. Majdan M, Dmoszynska A, Wojtaszko M, et al. Chronic myelogenous leukemia associated with rapidly progressive glomerulonephritis. Nephrol Dial Transplant 1994;9:562-3.
14. Rydel JJ, Korbert SM, Borok RZ, et al. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995;25:534-42.
15. Nagai R, Cattran DC, Pei Y. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clin Nephrol 1994;42:18-21.
16. Korbert SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998;9:1333-40.
17. Meyrier A, Noel LH, Auriche P, et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994;45:1446-56.
18. Talwar K, Dasch SC, Kucheria K. A case of chronic myeloid leukemia complicated with minimal change nephritic syndrome. Acta Haematol 2003;109:101-3.
19. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
20. Kantarjian H, Smith T, O'Brien S, et al. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon alpha therapy. The Leukemia Service. Ann Intern Med 1995;122:254-61.
21. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 1995;13:2401-7.
22. Jadoul M, Piessevaux H, Ferrant A, et al. Renal thrombotic microangiopathy in patients with chronic myelogenous leukemia treated with interferon-α2b. Nepnrol Dial Transplant 1995;10:111-13.